Sowell Financial Services’s MacroGenics MGNX Stock Holding History

Sowell Financial Services’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-324	Closed	-$10K	–	1851
2021 Q1	$10K	Buy	+324	New	+$7.87K	﹤0.01%	2317

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sowell Financial Services's MGNX Position: Q2 2021 in Review

Sowell Financial Services sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 324 shares — an estimated $10K sold.

Sowell Financial Services first reported a position in MGNX in Q1 2021 and held it in 1 quarter. The position peaked at $10K in Q1 2021. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

Sowell Financial Services reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 324 MacroGenics shares in Q2 2021, an estimated $10K.
Sowell Financial Services first reported a position in MacroGenics in Q1 2021 and held it in 1 quarter.
Sowell Financial Services's MacroGenics position peaked at $10K in Q1 2021.
149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.